0001171843-17-005589.txt : 20170918 0001171843-17-005589.hdr.sgml : 20170918 20170918161528 ACCESSION NUMBER: 0001171843-17-005589 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170914 FILED AS OF DATE: 20170918 DATE AS OF CHANGE: 20170918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NOYES TIMOTHY P CENTRAL INDEX KEY: 0001185035 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 171090068 MAIL ADDRESS: STREET 1: 1365 MAIN STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-0102 MAIL ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 formfour.xml FORM 4 X0306 4 2017-09-14 0 0001359931 PROTEON THERAPEUTICS INC PRTO 0001185035 NOYES TIMOTHY P C/O PROTEON THERAPEUTICS 200 WEST STREET WALTHAM MA 02451 1 1 0 0 President and CEO Common Stock 2017-09-14 4 D 0 4854 1.454 D 53888 D Common Stock 2017-09-15 4 D 0 5146 1.479 D 48742 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017. The selling price of $1.454 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $1.425 to $1.475. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The selling price of $1.479 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $1.475 to $1.50. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ George A. Eldridge as attorney-in-fact for Timothy P. Noyes 2017-09-18